K. Towlson

发表

Domperidone and levodopa in Parkinson's disease.

J. Parkes, A. Dolan, G. Finnerty, 1984, British journal of clinical pharmacology.

Do patients with advanced breast cancer benefit from chemotherapy?

R. Rubens, A. Ramirez, M. Leaning, 1998, British Journal of Cancer.

A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.

A. Howell, H. Earl, D. Miles, 1998, Blood.

Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning – evidence for a superior outcome using melphalan combined with total body irradiation

N. Russell, J. Cavenagh, P. Mahendra, 2005, British journal of haematology.

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

G. Mufti, N. Russell, J. Cavenagh, 2008, Bone Marrow Transplantation.

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

J. Taylor‐Papadimitriou, D. Miles, M. Reddish, 1996, British Journal of Cancer.

A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein- 1) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin, and Cyclophosphamide Chemotherapy

A. Howell, H. Earl, D. Miles, 1998 .

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

J. Cavenagh, R. Chopra, A. Davies, 2002, Blood.

The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma

N. Russell, J. Cavenagh, K. Peggs, 2003, British journal of haematology.

The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.

C. Crawley, N. Russell, R. Clark, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Br. J. Cancer '."

N. Dobbs, C. Twelves, R. Rubens, 2022 .

The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study

J. Gribben, S. Mackinnon, D. Linch, 2008, Hematology.

Quality of Life: Outcome Evaluation

R. Rubens, K. Towlson, 1992, Journal of palliative care.

Epirubicin for pretreated advanced ovarian cancer.

R. Coombes, M. Slevin, R. Stein, 1990, European journal of cancer.

The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland

C. Craddock, N. Russell, J. Apperley, 2004, British Journal of Haematology.

Appropriate chemotherapy for palliating advanced cancer.

M. Slevin, R. Rubens, A. Ramirez, 1992, BMJ.

Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.

C. Craddock, J. Snowden, K. Peggs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancer.

N. Dobbs, C. Twelves, A. Ramirez, 1993, European journal of cancer.